driven by the PitchBook Platform
Developer of ultrasensitive immunoassays. The company's core ZEPTACSYS technology platform is used for the targeted delivery of radio and chemo therapeutic drugs for cancer treatments.
You’re viewing a free company profile from the PitchBook Platform. To explore Akrivis Technologies’s full profile, request a free trial.
© 2018 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.